Cite

HARVARD Citation

    Grøn, K. et al. (n.d.). OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden. Annals of the rheumatic diseases. p. 208. [Online]. 
  
Back to record